Novo Nordisk (NVO) stock jumped 12% in pre-market trading Friday after it released promising results of an early-stage weight loss drug trial.
Read more...
Read More Details
Finally We wish PressBee provided you with enough information of ( Novo Nordisk stock surges 12% as an Ozempic alternative shows promising weight loss )
Also on site :
- Men have hundreds more saved in ‘rainy day’ funds than women, research indicates
- Trump announces U.S.-China trade talks in London
- China consumer prices slump again, deepening deflation worries as demand stays weak